Eli Lilly’s Obesity Drugs Drive Massive Revenue GrowthBy Press Room6 August 2026 In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and…
First Pill For Obstructive Sleep Apnea Shows Promise In Phase 3 StudyBy Press Room30 June 2025 You could say that it’s difficult to mask the challenges that people with obstructive sleep apnea face every day. But…